Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Lapicka-Bodzioch, K; Bodzioch, M; Krull, M; Kielar, D; Probst, M; Kiec, B; Andrikovics, H; Bottcher, A; Hubacek, J; Aslanidis, C; Suttorp, N; Schmitz, G
   Homogeneous assay based on 52 primer sets to scan for mutations of the ABCA1 gene and its application in genetic analysis of a new patient with familial high-density lipoprotein deficiency syndrome
   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
   
   K. Lapicka-Bodzioch et al., "Homogeneous assay based on 52 primer sets to scan for mutations of the ABCA1 gene and its application in genetic analysis of a new patient with familial high-density lipoprotein deficiency syndrome", BBA-MOL BAS, 1537(1), 2001, pp. 42-48
2. Brousseau, ME; Bodzioch, M; Schaefer, EJ; Goldkamp, AL; Kielar, D; Probst, M; Ordovas, JM; Aslanidis, C; Lackner, KJ; Rubins, HB; Collins, D; Robins, SJ; Wilson, PWF; Schmitz, G
   Common variants in the gene encoding ATP-binding cassette transporter 1 inmen with low HDL cholesterol levels and coronary heart disease
   ATHEROSCLEROSIS
   
   M.E. Brousseau et al., "Common variants in the gene encoding ATP-binding cassette transporter 1 inmen with low HDL cholesterol levels and coronary heart disease", ATHEROSCLER, 154(3), 2001, pp. 607-611
3. Kielar, D; Dietmaier, W; Langmann, T; Aslanidis, C; Probst, M; Naruszewicz, M; Schmitz, G
   Rapid quantification of human ABCA1 mRNA in various cell types and tissuesby real-time reverse transcription-PCR
   CLINICAL CHEMISTRY
   
   D. Kielar et al., "Rapid quantification of human ABCA1 mRNA in various cell types and tissuesby real-time reverse transcription-PCR", CLIN CHEM, 47(12), 2001, pp. 2089-2097
4. Schmitz, G; Aslanidis, C; Lackner, KJ
   Pharmacogenomics: implications for laboratory medicine
   CLINICA CHIMICA ACTA
   
   G. Schmitz et al., "Pharmacogenomics: implications for laboratory medicine", CLIN CHIM A, 308(1-2), 2001, pp. 43-53
5. Bodzioch, M; Aslanidis, C; Kacinski, M; Zhong, N; Wisniewski, KE; Schmitz, G
   Rapid detection of the two most common CLN2 mutations causing classical late infantile neuronal ceroid lipofuscinosis
   CLINICAL CHEMISTRY
   
   M. Bodzioch et al., "Rapid detection of the two most common CLN2 mutations causing classical late infantile neuronal ceroid lipofuscinosis", CLIN CHEM, 46(10), 2000, pp. 1696-1699
6. Bodzioch, M; Orso, E; Klucken, T; Langmann, T; Bottcher, L; Diederich, W; Drobnik, W; Barlage, S; Buchler, C; Porsch-Ozcurumez, M; Kaminski, WE; Hahmann, HW; Oette, K; Rothe, G; Aslanidis, C; Lackner, KJ; Schmitz, G
   The gene encoding ATP-binding cassette transporter 1 is mutated in Tangierdisease
   NATURE GENETICS
   
   M. Bodzioch et al., "The gene encoding ATP-binding cassette transporter 1 is mutated in Tangierdisease", NAT GENET, 22(4), 1999, pp. 347-351
7. Aslanidis, C; Nauck, M; Schmitz, G
   High-speed prothrombin G -> A 20210 and methylenetetrahydrofolate reductase C -> T 677 mutation detection using real-time fluorescence PCR and melting curves. (vol 27, pg 234, 1999)
   BIOTECHNIQUES
   
   C. Aslanidis et al., "High-speed prothrombin G -> A 20210 and methylenetetrahydrofolate reductase C -> T 677 mutation detection using real-time fluorescence PCR and melting curves. (vol 27, pg 234, 1999)", BIOTECHNIQU, 27(5), 1999, pp. 988-988
8. Aslanidis, C; Nauck, M; Schmitz, G
   High-speed prothrombin G -> A 20210 and methylenetetrahydrofolate reductase C -> T 677 mutation detection using real-time fluorescence PCR and melting curves
   BIOTECHNIQUES
   
   C. Aslanidis et al., "High-speed prothrombin G -> A 20210 and methylenetetrahydrofolate reductase C -> T 677 mutation detection using real-time fluorescence PCR and melting curves", BIOTECHNIQU, 27(2), 1999, pp. 234
9. Langmann, T; Buechler, C; Ries, S; Schaeffler, A; Aslanidis, C; Schuierer, M; Weiler, M; Sandhoff, K; de Jong, PJ; Schmitz, G
   Transcription factors Sp1 and AP-2 mediate induction of acid sphingomyelinase during monocytic differentiation
   JOURNAL OF LIPID RESEARCH
   
   T. Langmann et al., "Transcription factors Sp1 and AP-2 mediate induction of acid sphingomyelinase during monocytic differentiation", J LIPID RES, 40(5), 1999, pp. 870-880
10. Aslanidis, C; Schmitz, G
    High-speed apolipoprotein E genotyping and apolipoprotein B3500 mutation detection using real-time fluorescence PCR and melting curves
    CLINICAL CHEMISTRY
    
    C. Aslanidis e G. Schmitz, "High-speed apolipoprotein E genotyping and apolipoprotein B3500 mutation detection using real-time fluorescence PCR and melting curves", CLIN CHEM, 45(7), 1999, pp. 1094-1097
11. Aslanidis, C; Nauck, M; Schmitz, G
    High-speed detection of the two common alpha(1)-antitrypsin deficiency alleles Pi*Z and Pi*S by real-time fluorescence PCR and melting curves
    CLINICAL CHEMISTRY
    
    C. Aslanidis et al., "High-speed detection of the two common alpha(1)-antitrypsin deficiency alleles Pi*Z and Pi*S by real-time fluorescence PCR and melting curves", CLIN CHEM, 45(10), 1999, pp. 1872-1875
12. RIES S; BUCHLER C; SCHINDLER G; ASLANIDIS C; AMEIS D; GASCHE C; JUNG N; SCHAMBACH A; FEHRINGER P; VANIER MT; BELLI DC; GRETEN H; SCHMITZ G
    DIFFERENT MISSENSE MUTATIONS IN HISTIDINE-108 OF LYSOSOMAL ACID LIPASE CAUSE CHOLESTERYL ESTER STORAGE DISEASE IN UNRELATED COMPOUND HETEROZYGOUS AND HEMIZYGOTIC INDIVIDUALS
    Human mutation
    
    S. Ries et al., "DIFFERENT MISSENSE MUTATIONS IN HISTIDINE-108 OF LYSOSOMAL ACID LIPASE CAUSE CHOLESTERYL ESTER STORAGE DISEASE IN UNRELATED COMPOUND HETEROZYGOUS AND HEMIZYGOTIC INDIVIDUALS", Human mutation, 12(1), 1998, pp. 44-51
13. RIES S; BUCHLER C; LANGMANN T; FEHRINGER P; ASLANIDIS C; SCHMITZ G
    TRANSCRIPTIONAL REGULATION OF LYSOSOMAL ACID LIPASE IN DIFFERENTIATING MONOCYTES IS MEDIATED BY TRANSCRIPTION FACTORS SP1 AND AP-2
    Journal of lipid research
    
    S. Ries et al., "TRANSCRIPTIONAL REGULATION OF LYSOSOMAL ACID LIPASE IN DIFFERENTIATING MONOCYTES IS MEDIATED BY TRANSCRIPTION FACTORS SP1 AND AP-2", Journal of lipid research, 39(11), 1998, pp. 2125-2134
14. GASCHE C; ASLANIDIS C; KAIN R; EXNER M; HELBICH T; DEJACO C; SCHMITZ G; FERENCI P
    A NOVEL VARIANT OF LYSOSOMAL ACID LIPASE IN CHOLESTERYL ESTER STORAGEDISEASE-ASSOCIATED WITH MILD PHENOTYPE AND IMPROVEMENT ON LOVASTATIN
    Journal of hepatology
    
    C. Gasche et al., "A NOVEL VARIANT OF LYSOSOMAL ACID LIPASE IN CHOLESTERYL ESTER STORAGEDISEASE-ASSOCIATED WITH MILD PHENOTYPE AND IMPROVEMENT ON LOVASTATIN", Journal of hepatology, 27(4), 1997, pp. 744-750
15. LANGMANN T; BECKER A; ASLANIDIS C; NOTKA F; ULLRICH H; SCHWER H; SCHMITZ G
    STRUCTURAL ORGANIZATION AND CHARACTERIZATION OF THE PROMOTER REGION OF A HUMAN CARBOXYLESTERASE GENE
    Biochimica et biophysica acta, N. Gene structure and expression
    
    T. Langmann et al., "STRUCTURAL ORGANIZATION AND CHARACTERIZATION OF THE PROMOTER REGION OF A HUMAN CARBOXYLESTERASE GENE", Biochimica et biophysica acta, N. Gene structure and expression, 1350(1), 1997, pp. 65-74
16. BUCHLER C; SCHMIEDEKNECHT G; PIETZSCH A; KLUCKEN J; STANIEWICZ A; ASLANIDIS C; SCHMITZ G
    IDENTIFICATION OF DIFFERENTIATION AND ACTIVATION-DEPENDENT GENE CANDIDATES IN MONOCYTE MACROPHAGES/
    Atherosclerosis
    
    C. Buchler et al., "IDENTIFICATION OF DIFFERENTIATION AND ACTIVATION-DEPENDENT GENE CANDIDATES IN MONOCYTE MACROPHAGES/", Atherosclerosis, 129(1), 1997, pp. 8-8
17. RIES S; ASLANIDIS C; BUCHLER C; FEHRINGER P; SCHMITZ G
    MODULATION OF LYSOSOMAL ACID LIPASE (LAL) BY DEFINED MUTATIONS (CESD,WD), REGULATORY ELEMENTS (SP1, AP2, NF-KAPPA-B) AND CELL-DIFFERENTIATION IN MONOCYTE MACROPHAGES/
    Atherosclerosis
    
    S. Ries et al., "MODULATION OF LYSOSOMAL ACID LIPASE (LAL) BY DEFINED MUTATIONS (CESD,WD), REGULATORY ELEMENTS (SP1, AP2, NF-KAPPA-B) AND CELL-DIFFERENTIATION IN MONOCYTE MACROPHAGES/", Atherosclerosis, 129(1), 1997, pp. 9-9
18. HUBACEK J; BUCHLER C; ASLANIDIS C; SCHMITZ G
    THE GENETIC-STRUCTURE OF LIPOPROTEIN-ASSOCIATED LPS-BINDING PROTEIN (LBP) IS RELATED TO THE PHOSPHOLIPID-(PLTP), CHOLESTERYL ESTER TRANSFERPROTEIN (CETP) AND BACTERICIDAL PERMEABILITY-INCREASING PROTEIN (BPI)GENES
    Atherosclerosis
    
    J. Hubacek et al., "THE GENETIC-STRUCTURE OF LIPOPROTEIN-ASSOCIATED LPS-BINDING PROTEIN (LBP) IS RELATED TO THE PHOSPHOLIPID-(PLTP), CHOLESTERYL ESTER TRANSFERPROTEIN (CETP) AND BACTERICIDAL PERMEABILITY-INCREASING PROTEIN (BPI)GENES", Atherosclerosis, 129(1), 1997, pp. 26-26
19. HUBACEK JA; ASLANIDIS C; BUCHLER C; SCHMITZ G
    PSTI-POLYMORPHISM IN THE HUMAN BACTERICIDAL PERMEABILITY-INCREASING PROTEIN (BPI) GENE
    Clinical genetics
    
    J.A. Hubacek et al., "PSTI-POLYMORPHISM IN THE HUMAN BACTERICIDAL PERMEABILITY-INCREASING PROTEIN (BPI) GENE", Clinical genetics, 52(4), 1997, pp. 249-249
20. HUBACEK JA; BUCHLER C; ASLANIDIS C; SCHMITZ G
    THE GENOMIC ORGANIZATION OF THE GENES FOR HUMAN LIPOPOLYSACCHARIDE-BINDING PROTEIN (LBP) AND BACTERICIDAL PERMEABILITY-INCREASING PROTEIN (BPI) IS HIGHLY CONSERVED
    Biochemical and biophysical research communications
    
    J.A. Hubacek et al., "THE GENOMIC ORGANIZATION OF THE GENES FOR HUMAN LIPOPOLYSACCHARIDE-BINDING PROTEIN (LBP) AND BACTERICIDAL PERMEABILITY-INCREASING PROTEIN (BPI) IS HIGHLY CONSERVED", Biochemical and biophysical research communications, 236(2), 1997, pp. 427-430
21. PIETZSCH A; BUCHLER C; ASLANIDIS C; SCHMITZ G
    IDENTIFICATION AND CHARACTERIZATION OF A NOVEL MONOCYTE MACROPHAGE DIFFERENTIATION-DEPENDENT GENE THAT IS RESPONSIVE TO LIPOPOLYSACCHARIDE,CERAMIDE, AND LYSOPHOSPHATIDYLCHOLINE/
    Biochemical and biophysical research communications
    
    A. Pietzsch et al., "IDENTIFICATION AND CHARACTERIZATION OF A NOVEL MONOCYTE MACROPHAGE DIFFERENTIATION-DEPENDENT GENE THAT IS RESPONSIVE TO LIPOPOLYSACCHARIDE,CERAMIDE, AND LYSOPHOSPHATIDYLCHOLINE/", Biochemical and biophysical research communications, 235(1), 1997, pp. 4-9
22. SCHWER H; LANGMANN T; DAIG R; BECKER A; ASLANIDIS C; SCHMITZ G
    MOLECULAR-CLONING AND CHARACTERIZATION OF A NOVEL PUTATIVE CARBOXYLESTERASE, PRESENT IN HUMAN INTESTINE AND LIVER
    Biochemical and biophysical research communications
    
    H. Schwer et al., "MOLECULAR-CLONING AND CHARACTERIZATION OF A NOVEL PUTATIVE CARBOXYLESTERASE, PRESENT IN HUMAN INTESTINE AND LIVER", Biochemical and biophysical research communications, 233(1), 1997, pp. 117-120
23. LANGMANN T; ASLANIDIS C; SCHUIERER M; SCHMITZ G
    DIFFERENTIATION-DEPENDENT EXPRESSION OF A HUMAN CARBOXYLESTERASE IN MONOCYTIC CELLS AND TRANSCRIPTION FACTOR-BINDING TO THE PROMOTER
    Biochemical and biophysical research communications
    
    T. Langmann et al., "DIFFERENTIATION-DEPENDENT EXPRESSION OF A HUMAN CARBOXYLESTERASE IN MONOCYTIC CELLS AND TRANSCRIPTION FACTOR-BINDING TO THE PROMOTER", Biochemical and biophysical research communications, 230(1), 1997, pp. 215-219
24. ASLANIDIS C; RIES S; BUCHLER C; FEHRINGER P; SCHMITZ G
    IMPORTANCE OF DEFINED MUTATIONS IN THE LAL GENE FOR THE MANIFESTATIONOF CESD AND WD AND CHARACTERIZATION OF THE LAL PROMOTER
    Molecular biology of the cell
    
    C. Aslanidis et al., "IMPORTANCE OF DEFINED MUTATIONS IN THE LAL GENE FOR THE MANIFESTATIONOF CESD AND WD AND CHARACTERIZATION OF THE LAL PROMOTER", Molecular biology of the cell, 7, 1996, pp. 1720-1720
25. ASLANIDIS C; RIES S; FEHRINGER P; BUCHLER C; KLIMA H; SCHMITZ G
    GENETIC AND BIOCHEMICAL-EVIDENCE THAT CESD AND WOLMAN-DISEASE ARE DISTINGUISHED BY RESIDUAL LYSOSOMAL ACID LIPASE ACTIVITY
    Genomics
    
    C. Aslanidis et al., "GENETIC AND BIOCHEMICAL-EVIDENCE THAT CESD AND WOLMAN-DISEASE ARE DISTINGUISHED BY RESIDUAL LYSOSOMAL ACID LIPASE ACTIVITY", Genomics, 33(1), 1996, pp. 85-93
26. RIES S; ASLANIDIS C; FEHRINGER P; CAREL JC; GENDREL D; SCHMITZ G
    A NEW MUTATION IN THE GENE FOR LYSOSOMAL ACID LIPASE LEADS TO WOLMAN-DISEASE IN AN AFRICAN KINDRED
    Journal of lipid research
    
    S. Ries et al., "A NEW MUTATION IN THE GENE FOR LYSOSOMAL ACID LIPASE LEADS TO WOLMAN-DISEASE IN AN AFRICAN KINDRED", Journal of lipid research, 37(8), 1996, pp. 1761-1765
27. SCHMIEDEKNECHT G; KERKHOFF C; ORSO E; STOHR J; ASLANIDIS C; NAGY GM; KNUECHEL R; SCHMITZ G
    ISOLATION AND CHARACTERIZATION OF A 14.5-KDA TRICHLOROACETIC-ACID-SOLUBLE TRANSLATIONAL INHIBITOR PROTEIN FROM HUMAN MONOCYTES THAT IS UP-REGULATED UPON CELLULAR-DIFFERENTIATION
    European journal of biochemistry
    
    G. Schmiedeknecht et al., "ISOLATION AND CHARACTERIZATION OF A 14.5-KDA TRICHLOROACETIC-ACID-SOLUBLE TRANSLATIONAL INHIBITOR PROTEIN FROM HUMAN MONOCYTES THAT IS UP-REGULATED UPON CELLULAR-DIFFERENTIATION", European journal of biochemistry, 242(2), 1996, pp. 339-351
28. ASLANIDIS C; DEJONG PJ; SCHMITZ G
    MINIMAL LENGTH REQUIREMENT OF THE SINGLE-STRANDED TAILS FOR LIGATION-INDEPENDENT CLONING (LIC) OF PCR PRODUCTS
    PCR methods and applications
    
    C. Aslanidis et al., "MINIMAL LENGTH REQUIREMENT OF THE SINGLE-STRANDED TAILS FOR LIGATION-INDEPENDENT CLONING (LIC) OF PCR PRODUCTS", PCR methods and applications, 4(3), 1994, pp. 172-177
29. BECKER A; BOTTCHER A; LACKNER KJ; FEHRINGER P; NOTKA F; ASLANIDIS C; SCHMITZ G
    PURIFICATION, CLONING, AND EXPRESSION OF A HUMAN ENZYME WITH ACYL-COENZYME-A - CHOLESTEROL ACYLTRANSFERASE ACTIVITY, WHICH IS IDENTICAL TO LIVER CARBOXYLESTERASE
    Arteriosclerosis and thrombosis
    
    A. Becker et al., "PURIFICATION, CLONING, AND EXPRESSION OF A HUMAN ENZYME WITH ACYL-COENZYME-A - CHOLESTEROL ACYLTRANSFERASE ACTIVITY, WHICH IS IDENTICAL TO LIVER CARBOXYLESTERASE", Arteriosclerosis and thrombosis, 14(8), 1994, pp. 1346-1355
30. ASLANIDIS C; LACKNER KJ; SCHMITZ G
    TRINUCLEOTIDE AND TETRANUCLEOTIDE REPEAT POLYMORPHISM IN THE LIPA GENE
    Human molecular genetics
    
    C. Aslanidis et al., "TRINUCLEOTIDE AND TETRANUCLEOTIDE REPEAT POLYMORPHISM IN THE LIPA GENE", Human molecular genetics, 3(12), 1994, pp. 2269-2269
31. ASLANIDIS C; KLIMA H; LACKNER KJ; SCHMITZ G
    GENOMIC ORGANIZATION OF THE HUMAN LYSOSOMAL ACID LIPASE GENE (LIPA)
    Genomics
    
    C. Aslanidis et al., "GENOMIC ORGANIZATION OF THE HUMAN LYSOSOMAL ACID LIPASE GENE (LIPA)", Genomics, 20(2), 1994, pp. 329-331
32. KLIMA H; ULLRICH K; ASLANIDIS C; FEHRINGER P; LACKNER KJ; SCHMITZ G
    A SPLICE JUNCTION MUTATION CAUSES DELETION OF A 72-BASE EXON FROM THEMESSENGER-RNA FOR LYSOSOMAL ACID LIPASE IN A PATIENT WITH CHOLESTERYLESTER STORAGE DISEASE
    The Journal of clinical investigation
    
    H. Klima et al., "A SPLICE JUNCTION MUTATION CAUSES DELETION OF A 72-BASE EXON FROM THEMESSENGER-RNA FOR LYSOSOMAL ACID LIPASE IN A PATIENT WITH CHOLESTERYLESTER STORAGE DISEASE", The Journal of clinical investigation, 92(6), 1993, pp. 2713-2718
33. SCHMITZ G; KLIMA H; ASLANIDIS C; ULLRICH K; FEHRINGER P; LACKNER KJ
    DEFECTIVE SPLICING OF THE LYSOSOMAL ACID LIPASE-MESSENGER RNA IN A PATIENT WITH CHOLESTERYL ESTER STORAGE DISEASE
    Circulation
    
    G. Schmitz et al., "DEFECTIVE SPLICING OF THE LYSOSOMAL ACID LIPASE-MESSENGER RNA IN A PATIENT WITH CHOLESTERYL ESTER STORAGE DISEASE", Circulation, 88(4), 1993, pp. 423-423